By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Can-Fite BioPharma Ltd. 

Reinhold Cohn House
P.O.Box: 4060
Tel Aviv      Israel
Phone: 03-7109330 Fax: 03-5606405


Drug Discovery

Company News
Can-Fite BioPharma (CFBI) To Deliver 2 Presentations On Its Cancer Drug CF102 At The 20th World Congress On Advances In Oncology And 18th International Symposium On Molecular Medicine On October 8-10, 2015 In Athens 10/7/2015 6:43:19 AM
Can-Fite BioPharma (CFBI) To Present CF101 Psoriasis Data At Late Breaking Session Of The EADV Congress In Copenhagen On October 10, 2015 9/29/2015 10:39:52 AM
Can-Fite BioPharma (CFBI) Closes $9 Million Registered Direct Offering 9/25/2015 11:34:43 AM
Can-Fite BioPharma (CFBI) Announces $9 Million Registered Direct Offering 9/21/2015 11:24:45 AM
FDA Grants Fast Track Designation To Can-Fite BioPharma (CFBI)'s CF102 In The Treatment Of Liver Cancer 9/17/2015 6:51:24 AM
Can-Fite BioPharma (CFBI) To Present At Rodman & Renshaw 17th Annual Global Investment Conference On September 9, 2015 9/1/2015 7:01:01 AM
Can-Fite BioPharma (CFBI) Reports Financial Results For Six Months Ended June 30, 2015 8/28/2015 6:53:41 AM
WHO Accepted "Piclidenoson" As Proposed New Generic Name For Can-Fite BioPharma (CFBI)'s Lead Drug Candidate CF101 7/29/2015 11:36:38 AM
Can-Fite BioPharma (CFBI) Joins Israeli Life Sciences Delegation to Japan On July 28 - 30, 2015 7/23/2015 11:54:44 AM
Can-Fite BioPharma (CFBI)'s CF602 Sexual Dysfunction Drug Backed By New Preclinical Data Progresses Towards An IND 6/29/2015 6:39:00 AM